Pfizer Declares Third-Quarter 2025 Dividend
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company's common stock, payable September 2, 2025, to holders of the Common Stock of record at the close of business on July 25, 2025. The third-quarter 2025 cash dividend will be the 347th consecutive quarterly dividend paid by Pfizer.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Alaska Commissioner of Revenue Adam Crum and Prospr Aligned Announce Launch of The Frontier Economic Fund (NYSE: AKAF)
ANCHORAGE, Alaska--(BUSINESS WIRE)--Alaska, long known as America's last frontier, is stepping into a new era of economic leadership. Today, Alaska Commissioner of Revenue Adam Crum, in partnership with Prospr Aligned, announced the launch of The Frontier Economic Fund (NYSE: AKAF), a new investment vehicle focused on companies driving sustainable growth, local job creation, and long-term investment across Alaska. 'There's a real alignment happening between Alaska's strengths and the country's needs,' Crum added. 'This fund creates a bridge between that momentum and people who want to support it.' Share 'Alaska, America's resource powerhouse, is now positioned as a critical solution for national priorities like energy security and supply chain resilience with the launch of The Frontier Economic Fund,' said Commissioner Crum. 'AKAF represents a fundamental shift, prioritizing our top economic sectors including energy development, mining, tourism, cargo, transportation, and retail that make Alaska's economy robust and prosperous. The more than 130 companies initially included in the index have prioritized local employment, local investment, and long-term strategic importance for the state. This fund is about telling Alaska's story to more people and inviting them to help shape what comes next.' Alaska added 7,700 jobs in 2024, surpassing expectations and returning to pre-pandemic employment levels. Construction employment is up 25 percent since 2019, and the energy sector is regaining strength. The Frontier Economic Fund highlights these trends by tracking 137 companies with meaningful operations, workforce presence, and capital investment in the state. 'There's a real alignment happening between Alaska's strengths and the country's needs,' Crum added. 'This fund creates a bridge between that momentum and people who want to support it.' As part of the team behind the fund, Prospr Aligned views the launch as a moment of opportunity not just for investors, but for Alaskans. Vident Asset Management is the ETF fund asset manager and index creator. 'Alaska has always delivered for the country. Now we are offering a way for Alaskans, and anyone who believes in the state's potential, to invest back into the future of this incredible region,' said Derek Kreifels, CEO of Prospr Aligned. The Frontier Economic Fund launched on June 25, with an NYSE bell-ringing scheduled for July 2. To learn more, visit At Prospr Aligned, our mission is to empower investors to align their investments with their values—taking back control and amplifying their voice to ensure capital is used with integrity, not ideology. As a leading consulting partner for institutional investors, we deliver tailored business solutions that reflect client's values without compromising fiduciary excellence. We believe true prosperity is built on alignment—where every dollar reflects your values and where fiduciary duty is upheld. In short, we work to focus investors capital on returns, not politics.
Business Wire
an hour ago
- Business Wire
HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc.
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Sookdeo v. Hims & Hers Health, Inc., et al., Case No. 3:25-cv-05315, on behalf of persons and entities that purchased or otherwise acquired Hims & Hers Health, Inc. ('Hims' or the 'Company') (NYSE: HIMS) securities between , inclusive (the 'Class Period'). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the 'Exchange Act'). HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc. Share Investors are hereby notified that they have until 60 days from this notice to move the Court to serve as lead plaintiff in this action. IF YOU SUFFERED A LOSS ON YOUR HIMS INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Happened? On April 29, 2025, Hims announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of 'a bundled offering of Novo Nordisk's FDA-approved Wegovy on the Hims & Hers platform.' On June 23, 2025, before the market opened, Novo Nordisk issued a press release announcing that it was terminating its partnership with Hims, 'based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' The press release stated that Hims 'has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization.'' The press release further stated '[b]ased on Novo Nordisk's investigation, the 'semaglutide' active pharmaceutical ingredients that are in the knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers in China' which 'FDA has never authorized or approved' and which may contain 'unsafe and illicit foreign ingredients.' On this news, the Company's share price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025, on unusually heavy trading volume. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Hims was engaged in the 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk;' (2) that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Contact Us To Participate or Learn More: If you purchased Hims securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please HERE or contact us at: Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Telephone: 310-914-5007 Email: info@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
2 hours ago
- Business Wire
SabbaticalHomes Celebrates 25 Years of Housing Minds on the Move
LOS ANGELES--(BUSINESS WIRE)--SabbaticalHomes celebrates its 25th anniversary in 2025. With more than 2 million members in 65 countries, the international housing platform has long been the trusted resource for academics and scholars seeking temporary accommodations worldwide. As higher education faces global uncertainty and housing costs continue to climb, SabbaticalHomes is more relevant than ever. A Home for Scholars Founded in 2000 by Nadege Conger, SabbaticalHomes was inspired by personal experience. As part of an academic family, Conger witnessed how difficult it was for scholars to find suitable housing while working abroad. Seeing the potential of the internet to connect like-minded people, she coded the first version of the site herself—long before the plethora of short-term rental platforms emerged. Despite international disruptions like 9/11, economic downturns, and COVID-19, the company remains focused on its mission: supporting those who advance knowledge through research, writing, and education. About the Founder Originally from France and now based in Southern California, Conger earned her MBA from McGill University in Montreal after studying in France and Canada. Her early career included roles at Disney Paris and Deloitte & Touche, but she sought a more meaningful path. 'I'm particularly proud that SabbaticalHomes has grown organically, driven by purpose rather than venture capital,' said Conger. 'Each listing is more than a home—it's a vessel for thinkers, helping them contribute to society. We prioritize trust and respect over profits.' A Global Academic Community SabbaticalHomes connects professors, postdocs, teachers, graduate students, and university staff as well as writers, scientists, artists, journalists, filmmakers, and doctors—people who value lifelong learning and intellectual exchange. Its members include Nobel laureates, Fulbright scholars, and fellowship recipients worldwide. Many return year after year, sharing testimonials that reflect the platform's deep impact and community-first approach. How It Works Members list homes for rent or exchange with house-sitting and sharing options. They arrange details independently and directly—checking references, drafting contracts, and handling payments. This model encourages trust, flexibility, and authentic personal connections. With flat listing and match fees, SabbaticalHomes serves users at all career stages. Looking Ahead As it marks 25 years, SabbaticalHomes continues to support 'Minds on the Move.' With a strong foundation and a loyal community, the platform is well-positioned to empower scholars and thought leaders for decades to come. For more information, visit
